{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T14:16:54Z","timestamp":1771337814283,"version":"3.50.1"},"reference-count":18,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,1]]},"abstract":"<jats:sec>\n                    <jats:title>Objectives:<\/jats:title>\n                    <jats:p>Venoarterial extracorporeal membrane oxygenation (ECMO) is associated with neurologic complications but their impact on long-term outcomes are poorly understood. Our objective was to assess the association of neurologic complications with death and new disability at 6 months.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design:<\/jats:title>\n                    <jats:p>Prospective, multicenter, observational study.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Setting:<\/jats:title>\n                    <jats:p>Thirty ECMO centers in Australia and New Zealand between February 2019 and December 2022.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Subjects:<\/jats:title>\n                    <jats:p>seven hundred four adult patients admitted to the ICU on venoarterial ECMO other than for extracorporeal cardiopulmonary resuscitation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Interventions:<\/jats:title>\n                    <jats:p>None.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Measurement and Main Results:<\/jats:title>\n                    <jats:p>Patients were divided according to whether they experienced neurologic complications. Neurologic complications include diffuse cerebral ischemia, stroke, cerebral hemorrhage, and brain death. The primary outcome was a composite of death or new disability at 6 months. Secondary outcomes included disability measured by the World Health Organization Disability Assessment Schedule and quality of life measured with EuroQoL 5D five levels. The median age of patients was 54.5 years (42\u201364 yr) and 259 (36.8%) were female. The primary outcome was available for 613 of 706 patients (86.2%). Of these, 425 patients (69.3%) had either died or had new disability at 6 months. Neurologic events occurred in 85 patients (12%). Patients who experienced neurologic complications were at increased risk of death or new disability (risk difference [RD], 17.28% [6.44\u201325.92%]). This was primarily due to an increased risk of mortality RD, 23.75 (12.06\u201334.75) rather than new disability (RD, \u201311.90% [\u201330.58% to 13.56%]). These findings were consistent across types of complications and after adjustment for confounders. Patients with neurologic complications more commonly had ECMO discontinued due to a perceived poor prognosis (odds ratio, 2.7; 95% CI, 1.35\u201324.7).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Neurologic complications during ECMO increased the risk of death and disability at 6 months, primarily driven by increased death at 6 months. Prevention of these complications and development of better prognostic tools for functional outcomes should be prioritized.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/ccm.0000000000006938","type":"journal-article","created":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T15:00:22Z","timestamp":1762786822000},"page":"175-186","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Neurologic Complications During Venoarterial Extracorporeal Membrane Oxygenation and Their Implications for 6-Month Patient-Centered Outcomes"],"prefix":"10.1097","volume":"54","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3137-4895","authenticated-orcid":false,"given":"Alastair","family":"Brown","sequence":"first","affiliation":[{"name":"Australia and New Zealand Intensive Care Research Centre (ANZIC-RC), School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, Australia"},{"name":"Department of Critical Care Medicine, St Vincent\u2019s Hospital Melbourne, Melbourne, VIC, Australia"},{"name":"Department of Intensive Care and Hyperbaric Medicine, Alfred Health, Melbourne, VIC, Australia"},{"name":"Department of Intensive Care, Austin Health, Melbourne, VIC, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Dennis","sequence":"additional","affiliation":[{"name":"Sydney Medical School, University of Sydney, Sydney, NSW, Australia"},{"name":"Department of Cardiology, Royal Prince Alfred Hospital, Sydney, NSW, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nivedita","family":"Rattan","sequence":"additional","affiliation":[{"name":"Sydney Medical School, University of Sydney, Sydney, NSW, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vinodh","family":"Nanjayya","sequence":"additional","affiliation":[{"name":"Australia and New Zealand Intensive Care Research Centre (ANZIC-RC), School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, Australia"},{"name":"Department of Intensive Care and Hyperbaric Medicine, Alfred Health, Melbourne, VIC, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aidan","family":"Burrell","sequence":"additional","affiliation":[{"name":"Australia and New Zealand Intensive Care Research Centre (ANZIC-RC), School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, Australia"},{"name":"Department of Intensive Care and Hyperbaric Medicine, Alfred Health, Melbourne, VIC, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ary","family":"Serpa Neto","sequence":"additional","affiliation":[{"name":"Australia and New Zealand Intensive Care Research Centre (ANZIC-RC), School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, Australia"},{"name":"Department of Intensive Care, Austin Health, Melbourne, VIC, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9002-2075","authenticated-orcid":false,"given":"Carol","family":"Hodgson","sequence":"additional","affiliation":[{"name":"Australia and New Zealand Intensive Care Research Centre (ANZIC-RC), School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, Australia"},{"name":"Department of Intensive Care and Hyperbaric Medicine, Alfred Health, Melbourne, VIC, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"for the EXCEL (a Comprehensive Binational Registry on the Treatment and Outcomes of Patients Requiring Extracorporeal Membrane Oxygenation [ECMO]) Study Investigators and the International ECMO Network","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2025,11,10]]},"reference":[{"key":"R1-20260106","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1111\/aor.13331","article-title":"VA-ECMO support in nonsurgical patients with refractory cardiogenic shock: Pre-implant outcome predictors.","volume":"43","author":"Fux","year":"2019","journal-title":"Artif Organs"},{"key":"R2-20260106","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1097\/MAT.0000000000000475","article-title":"Extracorporeal life support organization registry international report 2016.","volume":"63","author":"Thiagarajan","year":"2017","journal-title":"ASAIO J"},{"key":"R3-20260106","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.jcrc.2019.05.011","article-title":"Venoarterial extracorporeal membrane oxygenation: A systematic review of selection criteria, outcome measures and definitions of complications.","volume":"53","author":"Burrell","year":"2019","journal-title":"J Crit Care"},{"key":"R4-20260106","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/s13613-016-0196-7","article-title":"Predictive factors of bleeding events in adults undergoing extracorporeal membrane oxygenation.","volume":"6","author":"Aubron","year":"2016","journal-title":"Ann Intensive Care"},{"key":"R5-20260106","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1097\/CCM.0000000000003954","article-title":"Core outcome measures for research in critically ill patients receiving extracorporeal membrane oxygenation for acute respiratory or cardiac failure: An international, multidisciplinary, modified Delphi consensus study*.","volume":"47","author":"Hodgson","year":"2019","journal-title":"Crit Care Med"},{"key":"R6-20260106","doi-asserted-by":"crossref","first-page":"427","DOI":"10.3390\/medicina58030427","article-title":"Long-term follow-up of survivors of extracorporeal life support therapy for cardiogenic shock: Are they really survivors?","volume":"58","author":"Berger","year":"2022","journal-title":"Medicina"},{"key":"R8-20260106","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/S2213-2600(22)00248-X","article-title":"Incidence of death or disability at 6 months after extracorporeal membrane oxygenation in Australia: A prospective, multicentre, registry-embedded cohort study.","volume":"10","author":"Hodgson","year":"2022","journal-title":"Lancet Respir Med"},{"key":"R9-20260106","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/s13613-018-0475-6","article-title":"Ischemic and hemorrhagic brain injury during venoarterial-extracorporeal membrane oxygenation.","volume":"8","author":"Guennec","year":"2018","journal-title":"Ann Intensive Care"},{"key":"R10-20260106","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.jcrc.2015.11.009","article-title":"Incidence and predictors of ischemic cerebrovascular stroke among patients on extracorporeal membrane oxygenation support.","volume":"32","author":"Omar","journal-title":"J Crit Care"},{"key":"R11-20260106","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.athoracsur.2013.09.008","article-title":"Complications of extracorporeal membrane oxygenation for treatment of cardiogenic shock and cardiac arrest: A meta-analysis of 1,866 adult patients.","volume":"97","author":"Cheng","year":"2014","journal-title":"Ann Thorac Surg"},{"key":"R12-20260106","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.jcrc.2017.02.014","article-title":"Anticoagulation practices and the prevalence of major bleeding, thromboembolic events, and mortality in venoarterial extracorporeal membrane oxygenation: A systematic review and meta-analysis.","volume":"39","author":"Sy","year":"2017","journal-title":"J Crit Care"},{"key":"R13-20260106","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/s13613-022-01067-9","article-title":"Extracorporeal membrane oxygenation for cardiogenic shock: A meta-analysis of mortality and complications.","volume":"12","author":"Rajsic","year":"2022","journal-title":"Ann Intensive Care"},{"key":"R14-20260106","doi-asserted-by":"crossref","first-page":"e964","DOI":"10.1097\/CCM.0000000000001865","article-title":"In-hospital neurologic complications in adult patients undergoing venoarterial extracorporeal membrane oxygenation.","volume":"44","author":"Lorusso","year":"2016","journal-title":"Crit Care Med"},{"key":"R15-20260106","doi-asserted-by":"crossref","first-page":"721774","DOI":"10.3389\/fmed.2021.721774","article-title":"Neurologic complications in adult post-cardiotomy cardiogenic shock patients receiving venoarterial extracorporeal membrane oxygenation: A cohort study.","volume":"8","author":"Hou","year":"2021","journal-title":"Front Med"},{"key":"R16-20260106","doi-asserted-by":"crossref","first-page":"e897","DOI":"10.1097\/CCM.0000000000004498","article-title":"Modifiable risk factors and mortality from ischemic and hemorrhagic strokes in patients receiving venoarterial extracorporeal membrane oxygenation: Results from the extracorporeal life support organization registry.","volume":"48","author":"Cho","year":"2020","journal-title":"Crit Care Med"},{"key":"R17-20260106","doi-asserted-by":"crossref","first-page":"698242","DOI":"10.3389\/fmed.2021.698242","article-title":"Neurological complications of veno-arterial extracorporeal membrane oxygenation: A retrospective case-control study.","volume":"8","author":"Luo","year":"2021","journal-title":"Front Med"},{"key":"R18-20260106","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1097\/CCM.0000000000003223","article-title":"Acute neurologic complications during extracorporeal membrane oxygenation.","volume":"46","author":"Sutter","year":"2018","journal-title":"Crit Care Med"},{"key":"R19-20260106","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1186\/s12955-016-0537-0","article-title":"Health-related quality of life measured using the EQ-5D\u20135L: South Australian population norms.","volume":"14","author":"McCaffrey","year":"2016","journal-title":"Health Qual Life Out"}],"container-title":["Critical Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CCM.0000000000006938","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T15:02:18Z","timestamp":1767711738000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/CCM.0000000000006938"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,10]]},"references-count":18,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/ccm.0000000000006938","relation":{},"ISSN":["0090-3493","1530-0293"],"issn-type":[{"value":"0090-3493","type":"print"},{"value":"1530-0293","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,10]]}}}